We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

By MedImaging International staff writers
Posted on 22 Mar 2024
Print article
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without prompt treatment. Considering the importance of early detection, researchers have now developed an artificial intelligence (AI) system that automatically and reliably detects cardiac amyloidosis during scintigraphy imaging.

The new AI system was developed and validated by an international research team led by Medical University Vienna (Vienna, Austria), utilizing data sets from 16,000 patients who underwent a scintigraphy imaging examination across Europe and Asia between 2010 and 2020. Scintigraphy, a nuclear medicine procedure, is instrumental in identifying various diseases, such as cancer, thyroid, kidney, and heart disease. The AI tool significantly enhances the speed of diagnosing cardiac amyloidosis by automatically detecting the condition during the scintigraphy imaging process.

The AI system’s accuracy was also rigorously tested by comparing it with the diagnostic capabilities of medical professionals. The results showed that the AI tool could identify cardiac amyloidosis with a reliability that matches or even surpasses that of medical experts. Further analysis by the research team delved into the relationship between AI-detected diagnoses of cardiac amyloidosis and subsequent health outcomes. The findings revealed that patients diagnosed with the condition by the AI tool faced double the risk of mortality and a more than seventeen-fold increase in the risk of developing heart failure compared to those not diagnosed with amyloidosis by the AI system.

"In the future, our findings and the technology we have developed could enable screening for cardiac amyloidosis among all scintigraphy patients, with the AI system evaluating the image data in parallel with doctors," said Clemens Spielvogel from MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy.

Related Links:
Medical University Vienna

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Ultrasound System
Voluson Signature 18
New
Digital Radiography Generator
meX+20BT lite

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.